omegabiotek.com Listed by incransom Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On August 01, 2025, the ransomware group known as incransom listed omegabiotek.com on its leak site, claiming a successful attack that involved the exfiltration of internal files. Public reporting confirms only that the organization was named by the group and that internal files were taken as part of a ransomware incident; the number of people affected remains unknown, and no further technical details have been disclosed.

This matters because Omega Bio-tek operates in a specialized manufacturing sector that supports clinical research, biotechnology, and agricultural work. Any compromise of internal systems can create lasting operational and privacy risks even when the full scope of the data taken is still unconfirmed.

Inside the incident

According to the available record, omegabiotek.com was listed by the incransom ransomware group on August 01, 2025. The group claims that internal files were exfiltrated during a ransomware attack. No public information has been released about the precise date the intrusion began, how the attackers gained access, the volume of data removed, or whether systems were encrypted in addition to the theft. The number of individuals potentially affected is listed as unknown. Beyond the group’s claim of file exfiltration, the incident details remain limited.

The group behind it: incransom

Incransom is a ransomware operation that follows the now-common double-extortion model: after gaining access to a network, operators typically steal data and then encrypt systems, threatening to publish the stolen material if a ransom is not paid. The group maintains a leak site where it posts victim names and, in some cases, sample files to pressure organizations. Like other ransomware crews active in recent years, incransom has targeted a range of mid-sized companies across manufacturing, professional services, and related sectors. Its public listings are claims made by the group itself and should be treated as unverified until independently confirmed. No additional statements from incransom specifically detailing the Omega Bio-tek incident beyond the listing and the assertion of internal-file exfiltration have been made public.

Who is omegabiotek.com?

Omega Bio-tek is an ISO 9001:2015 certified manufacturer specializing in nucleic acid isolation products used in clinical and basic research, biotechnology, and agricultural applications. Founded in 1998, the company develops extraction technologies based on magnetic beads, silica membranes, and salting-out methods, offering more than 900 kits and configurations for both manual and automated processing. Public company data place its workforce at approximately 145 employees and annual revenue near $50.1 million. It operates in the manufacturing sector and can be reached at the listed phone number (770) 931-8400. Organizations of this type routinely handle proprietary research data, customer and supplier records, quality-control documentation, and employee information, making any unauthorized access potentially consequential for both business continuity and the privacy of individuals connected to the firm.

What data was at risk

The only data type named in connection with the incident is “internal files” said to have been exfiltrated in the ransomware attack. Exact contents have not been disclosed. Companies in the nucleic-acid-product manufacturing space typically maintain research and development files, product formulations, quality-assurance records, customer order histories, supplier contracts, and standard corporate records such as employee and financial data. Because the public record does not specify which of these categories, if any, were among the taken files, the precise nature of the exposure remains unconfirmed.

The real-world impact

For individuals whose information may have been present in the internal files, the practical risks include potential misuse of personal or professional contact details, targeted phishing that references the company, or identity-related fraud if sensitive identifiers were stored. For Omega Bio-tek itself, the consequences can include operational disruption, the cost of forensic investigation and system restoration, possible regulatory notification duties, and reputational harm among research and biotech customers who rely on the integrity of its products and data-handling practices. Because the scale of the breach and the exact data types remain unknown, the full extent of these effects cannot yet be measured.

What to do if you're exposed

Anyone who has done business with or worked for Omega Bio-tek should treat the listing as a reason for heightened caution. Monitor financial and email accounts for unusual activity, enable multi-factor authentication wherever possible, and be skeptical of unsolicited messages that reference the company or claim to offer breach-related help. Change passwords on any accounts that may have reused credentials linked to work email. Readers can also run a free exposure scan of their email address to check whether their information has already appeared in known breach data sets. If you receive confirmation that your data was involved, follow any official guidance issued by the company and consider placing fraud alerts with major credit bureaus as an additional precaution.

AICompiled with AI assistance from public sources and published under our editorial standards.